Quinoline or isoquinoline substituted P2X7 antagonists
US8431704B2 · kind B2 · utility
21Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2009 |
| Grant date | Apr 30, 2013 |
| Priority date | — |
| Expiry date | Feb 12, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to novel compounds of formula (I) having P2X7 antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans. (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.